Current Perspectives on the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Listen Now

Topics Covered

• Review of Chronic Lymphocytic Leukemia
• Significant Role of Testing in Informing Treatment Choices
• First-Line Treatment Options
• Treatment for Relapsed & Refractory CLL
• Re-Testing Importance in Determining Treatment for 2nd & 3rd Line Treatments
• Current Perspectives on New & Emerging Treatments of CLL
• Updates on Clinical Trials & Their Significance for CLL
• Key Questions to Ask & Re-Ask Your CLL Health Care Team
• Practical & Psychosocial Support to Cope with CLL
• Questions for Our Panel of Experts

Our Panel of Experts

Erin Mulvey, MD

Assistant Professor of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine

Deborah M. Stephens, DO

Associate Professor of Medicine, Director of the Chronic Lymphocytic Leukemia and Richter's Program, Division of Hematology, University of North Carolina School of Medicine

Brian Koffman, MDCM, MS Ed

Co-Founder, Executive VP and Chief Medical Officer, CLL Society, Inc.

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Senior Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on June 06, 2024.